Literature DB >> 9359431

Metabolism and possible compartmentalization of inositol lipids in isolated rat-liver nuclei.

L R Vann1, F B Wooding, R F Irvine, N Divecha.   

Abstract

(1) The removal of the nuclear envelope from isolated rat-liver nuclei by washing with Triton X-100 (TX-100) was assessed by electron microscopy. All the envelope was removed by 0.04% (w/v) TX-100. (2) After this removal, phosphorylation of inositol lipids and diacylglycerol (DAG) from [gamma-32P]ATP still occurs, despite the near complete absence of detectable (by mass assay) DAG and PtdIns. This suggests that the majority of these two lipids in nuclei are present in the nuclear membrane, but the small amounts remaining after extraction, defined as intranuclear, are available for phosphorylation by lipid kinases (36% for DAG and 24% for PtdIns respectively, when expressed as a percentage of incorporation of intact nuclei). (3) PtdIns(4,5)P2 did not follow the same pattern as PtdIns and DAG; after removal of the nuclear membrane, 40% of the mass of this lipid was left in the nucleus. Moreover, a similar amount of PtdIns(4,5)P2 was also resistant to extraction with even higher concentrations of detergent, suggesting that PtdIns(4,5)P2 has a discrete intranuclear location, probably bound to nuclear proteins. (4) Addition of exogenous substrates, PtdIns, PtdIns(4)P and DAG, to membrane-depleted nuclei resulted in reconstitution of the majority of lipid phosphorylations from [gamma-32P]ATP (70%, 90% and 94% of intact nuclei respectively), suggesting a predominantly intranuclear location for the respective kinases. (5) Nuclei also showed phosphomonoesterase and phosphatidic acid hydrolase activity; dephosphorylation of pre-radiolabelled PtdIns(4)P, PtdIns(4,5)P2 and phosphatidic acid was observed when [gamma-32P]ATP was removed. However, some of the radioactivity was apparently resistant to these enzymes, suggesting the existence of multiple pools of these lipids. (6) Addition of excess non-radiolabelled ATP to nuclei pre-labelled with [gamma-32P]ATP resulted in an initial increase in the label in PtdIns(4,5)P2, implying a precursor-product relationship between the radiolabelled pools of PtdIns(4)P and PtdIns(4,5)P2. This was confirmed by analysis of the incorporation of 32P into the 4'-phosphate group of PtdIns(4)P and the individual 4'- and 5'-phosphate groups of PtdIns(4,5)P2. The data from these experiments also indicated that PtdIns(4,5)P2 can be produced from a pre-existing pool of PtdIns(4)P, as well as de novo from PtdIns. (7) Taken together our data suggest that isolated rat-liver nuclei have an intranuclear inositol lipid metabolism mechanism utilizing enzymes and substrates equivalent to those found in cytosol and plasma membrane, and that there may be some, but not complete, compartmentalization of the components of the nuclear inositol cycle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359431      PMCID: PMC1218831          DOI: 10.1042/bj3270569

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Purification and characterization of phosphatidylinositol 4-phosphate 5-kinases.

Authors:  N Divecha; C E Brooksbank; R F Irvine
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

Review 4.  Protein kinase C isoenzymes: divergence in signal transduction?

Authors:  H Hug; T F Sarre
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

5.  Migration of binucleate cells in the sheep placenta during normal pregnancy.

Authors:  F B Wooding; S G Chambers; J S Perry; M George; R B Heap
Journal:  Anat Embryol (Berl)       Date:  1980

Review 6.  Inositides and the nucleus and inositides in the nucleus.

Authors:  N Divecha; H Banfić; R F Irvine
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

7.  Nuclear diacylglycerol is increased during cell proliferation in vivo.

Authors:  H Banfić; M Zizak; N Divecha; R F Irvine
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

8.  Changes in polyphosphoinositide levels in rat liver nuclei in response to prolactin, a known hepatic mitogen.

Authors:  P Santi; A M Martelli; R S Gilmour; E Falcieri; R Rana; A Cataldi; G Lattanzi; R Bareggi; L Cocco
Journal:  Cell Signal       Date:  1992-07       Impact factor: 4.315

9.  Alpha-thrombin-induced nuclear sn-1,2-diacylglycerols are derived from phosphatidylcholine hydrolysis in cultured fibroblasts.

Authors:  M B Jarpe; K L Leach; D M Raben
Journal:  Biochemistry       Date:  1994-01-18       Impact factor: 3.162

10.  Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus.

Authors:  G Mazzotti; N Zini; E Rizzi; R Rizzoli; A Galanzi; A Ognibene; S Santi; A Matteucci; A M Martelli; N M Maraldi
Journal:  J Histochem Cytochem       Date:  1995-02       Impact factor: 2.479

View more
  32 in total

1.  Nuclear targeting of the beta isoform of type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its alpha-helix 7.

Authors:  A Ciruela; K A Hinchliffe; N Divecha; R F Irvine
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  A novel neuronal-specific splice variant of Type I phosphatidylinositol 4-phosphate 5-kinase isoform gamma.

Authors:  Maria-Luisa Giudici; Piers C Emson; Robin F Irvine
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

3.  Identification of nuclear phosphatidylinositol 4,5-bisphosphate-interacting proteins by neomycin extraction.

Authors:  Aurélia E Lewis; Lilly Sommer; Magnus Ø Arntzen; Yvan Strahm; Nicholas A Morrice; Nullin Divecha; Clive S D'Santos
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

4.  Phospholipase C delta 4 (PLCδ4) is a nuclear protein involved in cell proliferation and senescence in mesenchymal stromal stem cells.

Authors:  Marianna Kunrath-Lima; Marcelo Coutinho de Miranda; Andrea da Fonseca Ferreira; Camila Cristina Fraga Faraco; Mariane Izabella Abreu de Melo; Alfredo Miranda Goes; Michele Angela Rodrigues; Jerusa Araújo Quintão Arantes Faria; Dawidson Assis Gomes
Journal:  Cell Signal       Date:  2018-06-01       Impact factor: 4.315

Review 5.  Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes.

Authors:  Raymond D Blind
Journal:  Adv Biol Regul       Date:  2013-10-18

6.  Cytoplasmic and nuclear phospholipase C-beta 1 relocation: role in resumption of meiosis in the mouse oocyte.

Authors:  N Avazeri; A M Courtot; A Pesty; C Duquenne; B Lefèvre
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

7.  Comprehensive analysis of yeast surface displayed cDNA library selection outputs by exon microarray to identify novel protein-ligand interactions.

Authors:  Scott Bidlingmaier; Yong Wang; Yue Liu; Niu Zhang; Bin Liu
Journal:  Mol Cell Proteomics       Date:  2010-12-02       Impact factor: 5.911

8.  Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells.

Authors:  J H Clarke; A J Letcher; C S D'santos; J R Halstead; R F Irvine; N Divecha
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 9.  Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions.

Authors:  Yury J Sigal; Mark I McDermott; Andrew J Morris
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

10.  Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors.

Authors:  I V Boronenkov; J C Loijens; M Umeda; R A Anderson
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.